Cg Oncology Inc (CGON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 257,068 | 8,266 | 88,143 |
| Marketable Securities | 484,930 | 179,408 | 55,338 |
| Receivables | 781 | 92 | 303 |
| TOTAL | $754,210 | $194,124 | $147,208 |
| Non-Current Assets | |||
| PPE Net | 272 | 69 | 86 |
| Other Non-Current Assets | 315 | 5,108 | 453 |
| TOTAL | $587 | $5,177 | $539 |
| Total Assets | $754,797 | $199,301 | $147,747 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | N/A | N/A | 8,966 |
| Accounts payable and accrued liabilities | 6,517 | 3,242 | 985 |
| Accrued Expenses | 14,665 | 10,443 | 5,289 |
| Other current liabilities | N/A | 352 | N/A |
| TOTAL | $21,368 | $14,254 | $15,429 |
| Non-Current Liabilities | |||
| Long Term Debt | N/A | N/A | 6,532 |
| Other Non-Current Liabilities | 52 | 308,147 | 203,479 |
| TOTAL | $52 | $308,147 | $210,011 |
| Total Liabilities | $21,420 | $322,401 | $225,440 |
| Shareholders' Equity | |||
| Shares Outstanding, K | 76,217 | N/A | N/A |
| Common Shares | 8 | N/A | 0 |
| Retained earnings | -217,981 | -129,942 | -81,335 |
| TOTAL | $733,377 | $-123,100 | $-77,693 |
| Total Liabilities And Equity | $754,797 | $199,301 | $147,747 |